BFRI - Biofrontera Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Biofrontera Inc.
IPO Date: October 29, 2021
Sector: Healthcare
Industry: Drug Manufacturers - Specialty and Generic
Market Cap: $13.65M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.14 | 5.82%
Avg Daily Range (30 D): $0.05 | 4.00%
Avg Daily Range (90 D): $0.05 | 3.99%
Institutional Daily Volume
Avg Daily Volume: 1.4M
Avg Daily Volume (30 D): .62M
Avg Daily Volume (90 D): .45M
Trade Size
Avg Trade Size (Sh.): 278
Avg Trade Size (Sh.) (30 D): 336
Avg Trade Size (Sh.) (90 D): 348
Institutional Trades
Total Institutional Trades: 27
Avg Institutional Trade: $1.17M
Avg Institutional Trade (30 D): $2.12M
Avg Institutional Trade (90 D): $2.12M
Avg Institutional Trade Volume: .01M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $.74M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 4.51K
 
News
Jul 3, 2026 @ 11:55 AM
Photodynamic Therapy Market: Durable Growth with a...
Source: Researchandmarkets.Com
May 8, 2026 @ 8:00 PM
Biofrontera Inc. to Report First Quarter 2026 Fina...
Source: Na
Dec 4, 2025 @ 2:00 PM
Last Patient Completes Biofrontera’s Phase ...
Source: Biofrontera Inc.
Aug 14, 2025 @ 7:01 PM
Biofrontera Q2 Revenue Jumps 15%
Source: Hermann Luebbert
Aug 13, 2025 @ 9:20 PM
Biofrontera Inc. Reports Second Quarter 2025 Finan...
Source: Hermann Luebbert
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.45 $-.05 $-.41
Diluted EPS $-.45 $-.05 $-.41
Revenue $46.18M $12M $10.08M
Gross Profit
Net Income / Loss $-6.37M $-.6M $-4.75M
Operating Income / Loss $-6.56M $-.52M $-4.32M
Cost of Revenue
Net Cash Flow $.49M $M $M
PE Ratio    
Splits
Jul 05, 2023 1:20